Key result
Laparoscopic sleeve gastrectomy and one-anastomosis gastric bypass significantly reduced mean albuminuria at 12 months, with no significant difference between the procedures (P=0.78).
Why the study?
To examine the effect of weight-loss induced bariatric procedures on albuminuria levels among patients with obesity and diabetes.
Does laparoscopic sleeve gastrectomy compared to one-anastomosis gastric bypass reduce albuminuria levels in adult patients with morbid obesity and type 2 diabetes mellitus?
Cohort
Does laparoscopic sleeve gastrectomy compared to one-anastomosis gastric bypass reduce albuminuria levels in adult patients with morbid obesity and type 2 diabetes mellitus?
Absolute Event Rate: 9.92% vs 9.34%
p-value: p=0.78
Bariatric surgery (LSG or OAGB) significantly reduces the severity of albuminuria at 1 year in patients with morbid obesity and T2DM, with similar efficacy between the two procedures.
Bariatric surgery may reduce albuminuria in obese T2DM; leaves open whether LSG and OAGB differ long-term.
Aim: To examine the effect of weight-loss induced bariatric procedures on albuminuria levels among diabetic patients suffering from obesity. Methods: Adults patients who suffer from morbid obesity and type 2 diabetes mellitus (T2DM) were included in a prospective cohort study. Subjects were scheduled to undergo laparoscopic sleeve gastrectomy (LSG) or one-anastomosis gastric bypass (OAGB). The albumin-to-creatinine ratio (ACR) was adopted to assess the degree of albuminuria. Microalbuminuria was determined as a ratio of >2.5-30 mg/mmol and >3.5-30 mg/mmol for males and females, respectively, while macroalbuminuria was diagnosed when the ACR exceeded >30 mg/mmol. Results: The mean uACR decreased significantly from 20.95±16.89 to 9.92±12.69mg/mmol in LSG cohort (p <0.001), and from 19.52±16.65 to 9.34±11.77mg/mmol in the OAGB cohort, with no statistically considerable differences between both cohorts at the end of follow-up (p = 0.78). Twelve months after the procedures, the percentages of cases with microalbuminuria decreased significantly to 23.8% and 23.9%, respectively (p < 0.001); likewise, the percentages of cases with macroalbuminuria significantly decreased to 7.9% and 7.5% in the LSG and OAGB groups, respectively (p < 0.001). There were no statistically considerable differences between LSG and OAGB regarding the percentages of patients with micro or macroalbuminuria at the end of follow-up. Besides, there were no significant associations between the degree of weight loss and improvement (p = 0.959) or remission (p = 0.73) of microalbuminuria. Conclusion: Bariatric surgery significantly reduced the severity of albuminuria 1-year after the procedure, with no preference for one procedure over the other.
No takes yet. Share an insight, caveat, or question.
Salman et al. (2022) conducted a cohort in Morbid obesity and type 2 diabetes mellitus. Laparoscopic sleeve gastrectomy (LSG) vs. One-anastomosis gastric bypass (OAGB) was evaluated on Mean albumin-to-creatinine ratio (uACR) at 12 months (p=0.78). Laparoscopic sleeve gastrectomy and one-anastomosis gastric bypass significantly reduced mean albuminuria at 12 months, with no significant difference between the procedures (P=0.78).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: